/PRNewswire/ Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and.
The University of Cincinnati Cancer Center has announced they have begun enrolling patients in a new clinical trail testing a vaccine to treat pancreatic cancer.
The University of Cincinnati Cancer Center is enrolling patients in a new clinical trial to test a vaccine to treat pancreatic cancer, according to a press release.
A pancreatic cancer vaccine trial is now open for enrollment at the University of Cincinnati Cancer Center, the first trial of its kind in the Midwest, the university said in